A randomised controlled trial of the use of topical application of tranexamic acid in primary cemented total hip replacement

Completed

• Conditions: Musculoskeletal Diseases: total hip replacement; Musculoskeletal Diseases; Total hip replacement

• Registration Number: ISRCTN58762744
• Lead Sponsor: Record Provided by the NHSTCT Register - 2006 Update - Department of Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-09-29
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 124

Inclusion Criteria

Patients having unilateral primary cemented total hip replacement

Exclusion Criteria

1. Allergic to tranexamic acid
2. Pregnancy
3. History of DVT/pulmonary embolus
4. Patients involved in other trials
5. Known bleeding problems
6. Concurrent treatment with warfarin
7. Low dose molecular weight heparin or conventional heparin
8. Paget's disease or revision total hip replacement

Study & Design

• Study Type: Interventional
• Study Design: Not specified